Our number 1 criteria – expect results, not perfection!  Our proprietary software provides the tools to technically analyze over 15,000 stocks each week, in a matter of minutes.  While not perfect, we work to ensure our investment choices mitigate randomness and keep mistakes small and that, overall, no major loss occurs that will dramatically alter your account’s performance.

The rapid growth of a cell in the human body is called cancer.  Likewise, we believe that rapid growth in any one stock is not in the best interest of its shareholders in the long run.  Slow, steady growth through proper diversification is our mantra.

Such diversification starts by realizing that all companies – all investments – have a particular life cycle.  Our job is to know when the cycle of an investment should be bought, sold or shorted. 

Knowing what to buy is important.  Knowing when to sell is imperative.  Selling is the key to our success.  Our technical research has established confidence and volatility technical indicators that have been a big part of our performance.